药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Phenprocoumon
Tafamidis
The serum concentration of Prasterone can be increased when it is combined with Tafamidis.
Phenprocoumon
Lemborexant
The serum concentration of Lemborexant can be increased when it is combined with Prasterone.
Phenprocoumon
Cenobamate
The serum concentration of Prasterone can be decreased when it is combined with Cenobamate.
Phenprocoumon
Lasmiditan
The serum concentration of Prasterone can be increased when it is combined with Lasmiditan.
Phenprocoumon
Formononetin
The risk or severity of adverse effects can be increased when Prasterone is combined with Formononetin.
Phenprocoumon
Biochanin A
The risk or severity of adverse effects can be increased when Prasterone is combined with Biochanin A.
Phenprocoumon
Estradiol valerate
The risk or severity of adverse effects can be increased when Prasterone is combined with Estradiol valerate.
Phenprocoumon
Estradiol cypionate
The risk or severity of adverse effects can be increased when Prasterone is combined with Estradiol cypionate.
Phenprocoumon
Estradiol benzoate
The risk or severity of adverse effects can be increased when Prasterone is combined with Estradiol benzoate.
Phenprocoumon
Estradiol acetate
The risk or severity of adverse effects can be increased when Prasterone is combined with Estradiol acetate.
Phenprocoumon
Moxestrol
The risk or severity of adverse effects can be increased when Prasterone is combined with Moxestrol.
Phenprocoumon
Epimestrol
The risk or severity of adverse effects can be increased when Prasterone is combined with Epimestrol.
Phenprocoumon
Methallenestril
The risk or severity of adverse effects can be increased when Prasterone is combined with Methallenestril.
Phenprocoumon
Promestriene
The risk or severity of adverse effects can be increased when Prasterone is combined with Promestriene.
Phenprocoumon
Equol
The risk or severity of adverse effects can be increased when Prasterone is combined with Equol.
Phenprocoumon
Zeranol
The risk or severity of adverse effects can be increased when Prasterone is combined with Zeranol.
Phenprocoumon
Esterified estrogens
The risk or severity of adverse effects can be increased when Prasterone is combined with Esterified estrogens.
Phenprocoumon
Polyestradiol phosphate
The risk or severity of adverse effects can be increased when Prasterone is combined with Polyestradiol phosphate.
Phenprocoumon
Synthetic Conjugated Estrogens, B
The risk or severity of adverse effects can be increased when Prasterone is combined with Synthetic Conjugated Estrogens, B.
Phenprocoumon
Synthetic Conjugated Estrogens, A
The risk or severity of adverse effects can be increased when Prasterone is combined with Synthetic Conjugated Estrogens, A.